CD8A and non-small cell lung carcinoma: Another study of 31 patients with advanced NSCLC treated with ICI reported that baseline high CD8+ PD1+ levels in blood and low CD8+ PD1+ in tissue by immunohistochemistry were associated with better prognosis [38].